| Code | Description | Claims | Beneficiaries | Total Paid |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
9,632 |
2,387 |
$932K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
3,489 |
3,322 |
$198K |
| 97161 |
|
1,424 |
975 |
$133K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
6,315 |
5,540 |
$85K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
6,320 |
5,540 |
$82K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
3,584 |
3,194 |
$82K |
| 84443 |
Thyroid stimulating hormone (TSH) |
6,812 |
6,291 |
$42K |
| 80053 |
Comprehensive metabolic panel |
11,186 |
9,724 |
$34K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
937 |
602 |
$31K |
| 87536 |
|
574 |
528 |
$23K |
| 83655 |
|
3,880 |
3,225 |
$21K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,868 |
1,660 |
$20K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,805 |
833 |
$16K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
585 |
360 |
$14K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
723 |
601 |
$13K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
1,464 |
1,347 |
$13K |
| 71046 |
Radiologic examination, chest; 2 views |
1,337 |
1,217 |
$12K |
| 86480 |
|
557 |
517 |
$12K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
8,505 |
7,274 |
$12K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
7,443 |
6,998 |
$11K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
65 |
58 |
$11K |
| 80061 |
Lipid panel |
7,601 |
7,132 |
$10K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
2,213 |
2,052 |
$10K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
884 |
262 |
$10K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,073 |
2,656 |
$9K |
| 85027 |
|
7,814 |
6,899 |
$9K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,659 |
2,370 |
$8K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
172 |
109 |
$8K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
322 |
289 |
$8K |
| 36415 |
Collection of venous blood by venipuncture |
3,747 |
3,040 |
$8K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,677 |
2,434 |
$7K |
| 97162 |
|
68 |
57 |
$7K |
| 92557 |
|
172 |
158 |
$7K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
277 |
264 |
$6K |
| 86003 |
|
479 |
415 |
$5K |
| 87340 |
|
1,824 |
1,594 |
$5K |
| 87186 |
|
1,233 |
1,050 |
$5K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
310 |
108 |
$5K |
| 77066 |
Tomosynthesis, mammo |
56 |
55 |
$4K |
| 72110 |
|
236 |
216 |
$4K |
| 92567 |
|
264 |
241 |
$4K |
| 81511 |
|
110 |
98 |
$4K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
90 |
62 |
$3K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
69 |
43 |
$3K |
| 86780 |
|
847 |
776 |
$3K |
| 80076 |
|
1,063 |
956 |
$3K |
| 73562 |
|
317 |
289 |
$3K |
| 86706 |
|
830 |
757 |
$3K |
| 73030 |
|
287 |
258 |
$3K |
| 81001 |
|
3,557 |
3,152 |
$3K |
| 87070 |
|
1,738 |
1,508 |
$3K |
| 73564 |
|
156 |
145 |
$2K |
| 84439 |
|
1,462 |
1,376 |
$2K |
| 85610 |
|
1,891 |
1,495 |
$2K |
| 87081 |
|
906 |
811 |
$2K |
| 87517 |
|
78 |
68 |
$2K |
| 82274 |
|
442 |
419 |
$2K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
265 |
258 |
$2K |
| 81025 |
|
2,289 |
2,090 |
$2K |
| 86803 |
|
460 |
428 |
$2K |
| 83735 |
|
1,117 |
603 |
$2K |
| 84702 |
|
556 |
422 |
$2K |
| 82607 |
|
564 |
529 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
139 |
78 |
$2K |
| 86592 |
|
2,191 |
1,894 |
$2K |
| 82105 |
|
263 |
238 |
$2K |
| 86762 |
|
1,098 |
924 |
$2K |
| 84153 |
|
360 |
335 |
$2K |
| 85018 |
|
3,977 |
3,493 |
$1K |
| 85014 |
|
3,976 |
3,493 |
$1K |
| 83021 |
|
308 |
242 |
$1K |
| 82043 |
|
1,597 |
1,516 |
$1K |
| 87205 |
|
1,867 |
1,577 |
$1K |
| 87210 |
|
1,759 |
1,552 |
$1K |
| 73130 |
|
130 |
120 |
$1K |
| 82950 |
|
854 |
762 |
$1K |
| 86850 |
|
1,084 |
891 |
$1K |
| 86360 |
|
505 |
464 |
$1K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
42 |
12 |
$989.04 |
| 73610 |
|
63 |
54 |
$979.46 |
| 85651 |
|
1,098 |
1,003 |
$928.50 |
| 86901 |
|
1,138 |
948 |
$920.87 |
| 77065 |
Tomosynthesis, mammo |
16 |
16 |
$880.61 |
| J1631 |
Injection, haloperidol decanoate, per 50 mg |
60 |
37 |
$876.57 |
| 86359 |
|
505 |
464 |
$832.46 |
| 73630 |
|
80 |
73 |
$831.40 |
| 86038 |
|
183 |
165 |
$822.52 |
| 84481 |
|
393 |
376 |
$814.27 |
| 87147 |
|
853 |
719 |
$740.75 |
| 85730 |
|
691 |
641 |
$731.04 |
| 88142 |
|
565 |
485 |
$713.93 |
| 80074 |
|
69 |
67 |
$689.33 |
| 86140 |
|
760 |
692 |
$671.96 |
| 86900 |
|
1,122 |
932 |
$667.87 |
| 82746 |
|
244 |
231 |
$638.04 |
| 72100 |
|
55 |
54 |
$635.63 |
| 82728 |
|
420 |
393 |
$570.93 |
| 83550 |
|
290 |
278 |
$548.95 |
| 85007 |
|
784 |
618 |
$503.04 |
| 81003 |
|
1,038 |
936 |
$499.30 |
| 84480 |
|
298 |
256 |
$452.32 |
| 83540 |
|
449 |
420 |
$435.18 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
66 |
59 |
$424.23 |
| 87486 |
|
65 |
58 |
$423.95 |
| 87581 |
|
65 |
58 |
$379.38 |
| 82951 |
|
54 |
52 |
$295.88 |
| 87077 |
|
220 |
197 |
$244.91 |
| 84550 |
|
250 |
220 |
$228.57 |
| 73502 |
|
17 |
12 |
$222.95 |
| 82570 |
|
230 |
200 |
$199.23 |
| 83970 |
|
13 |
12 |
$167.80 |
| 84156 |
|
305 |
249 |
$159.37 |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
22 |
13 |
$123.05 |
| 84436 |
|
115 |
98 |
$118.53 |
| 86431 |
|
50 |
48 |
$75.13 |
| 87350 |
|
12 |
12 |
$75.00 |
| 83615 |
|
49 |
41 |
$66.40 |
| 84484 |
|
33 |
27 |
$51.24 |
| 86696 |
|
17 |
12 |
$39.86 |
| 82952 |
|
54 |
52 |
$33.78 |
| 82247 |
|
15 |
13 |
$24.97 |
| 86200 |
|
12 |
12 |
$21.38 |
| 84100 |
|
15 |
14 |
$16.13 |
| J2680 |
Injection, fluphenazine decanoate, up to 25 mg |
27 |
13 |
$0.00 |
| 85041 |
|
15 |
14 |
$0.00 |